240 related articles for article (PubMed ID: 16429220)
1. FDA labeling status of pediatric medications.
Yoon EY; Davis MM; El-Essawi H; Cabana MD
Clin Pediatr (Phila); 2006; 45(1):75-7. PubMed ID: 16429220
[No Abstract] [Full Text] [Related]
2. Off-label or off-limits?
Ritchey ML
J Urol; 2013 Jul; 190(1):8-9. PubMed ID: 23608037
[No Abstract] [Full Text] [Related]
3. New pediatric dosage rules: information and testing.
Feeg VD
Pediatr Nurs; 1998; 24(6):518, 613. PubMed ID: 10085992
[No Abstract] [Full Text] [Related]
4. Improving pediatric dosing through pediatric initiatives: what we have learned.
Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
[TBL] [Abstract][Full Text] [Related]
5. Drug prescribing. Licensing flaws.
Watts G
Health Serv J; 1999 Jan; 109(5639):suppl 9-11. PubMed ID: 10345648
[No Abstract] [Full Text] [Related]
6. FDA proposes more stringent pediatric-use labeling of prescription drug products.
Am J Hosp Pharm; 1993 Jan; 50(1):13, 16. PubMed ID: 8427271
[No Abstract] [Full Text] [Related]
7. Characteristics of container labeling in a sample of commonly prescribed children's oral medications.
Wallace LS; Keenum AJ; DeVoe JE
Res Social Adm Pharm; 2010 Dec; 6(4):272-9. PubMed ID: 21111385
[TBL] [Abstract][Full Text] [Related]
8. FDA problems with medications in the marketplace: III. 'Therapeutic orphans'.
Archambault GF
Hosp Formul; 1976 Dec; 11(12):690. PubMed ID: 1028797
[No Abstract] [Full Text] [Related]
9. Therapeutic orphans: who speaks for children?
Shirkey HC
South Med J; 1970 Nov; 63(11):1361-3. PubMed ID: 5475304
[No Abstract] [Full Text] [Related]
10. US FDA calls for technological attack on drug counterfeiting.
Ault A
Lancet; 2004 Feb; 363(9410):714. PubMed ID: 15005089
[No Abstract] [Full Text] [Related]
11. Pharmaceutical inserts: legal consequences.
Hirsh HL
Hosp Med Staff; 1979 Jul; 8(7):2-6. PubMed ID: 10242674
[TBL] [Abstract][Full Text] [Related]
12. Broader picture surrounding new pediatric labeling for topical corticosteroid therapy.
D'Alonzo GE
J Am Osteopath Assoc; 1999 Jan; 99(1):15-6, 18. PubMed ID: 9972090
[No Abstract] [Full Text] [Related]
13. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
[TBL] [Abstract][Full Text] [Related]
14. The FDA drug approval process: focus on pediatric labeling.
Brummel GL
Neonatal Netw; 2001 Apr; 20(3):49-51. PubMed ID: 12144214
[No Abstract] [Full Text] [Related]
15. Medication use during pregnancy and lactation: the new FDA drug labeling.
Tillett J
J Perinat Neonatal Nurs; 2015; 29(2):97-9. PubMed ID: 25919597
[No Abstract] [Full Text] [Related]
16. American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations.
Pediatrics; 1969 Mar; 43(3):463-5. PubMed ID: 5818481
[No Abstract] [Full Text] [Related]
17. Requirements for FDA-approved patient information spelled out in final rule.
Am J Health Syst Pharm; 1999 Jan; 56(2):107-8. PubMed ID: 10030523
[No Abstract] [Full Text] [Related]
18. From off-label prescribing towards a new FDA.
Tabarrok A
Med Hypotheses; 2009 Jan; 72(1):11-3. PubMed ID: 18835103
[TBL] [Abstract][Full Text] [Related]
19. Use of drugs for unlabeled indications.
Nightingale SL
Am Fam Physician; 1986 Sep; 34(3):269. PubMed ID: 3751849
[No Abstract] [Full Text] [Related]
20. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
Novak E; Allen PJ
Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
